Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Susanne J. Goldie, M.D.

Profile Picture
Other Positions

Dr. Sue J. Goldie, Roger Irving Lee Professor of Public Health, is a physician, decision analyst, and public health scientist working to improve the health of vulnerable populations across the globe. Renowned for her scholarship in decision science, commitment to policy translation, and innovative approach to interdisciplinary education, Goldie serves as the Director of both the Global Health Education and Learning Incubator (Harvard University) and the Center for Health Decision Science (Harvard T.H. Chan School of Public Health).

Internationally recognized for mathematical disease modeling and analyses to guide public health decision making, Goldie's research has focused on viruses of global health importance, cancer prevention, reproductive health, and maternal mortality. She has published 200 research papers, chapters, and technical reports and served as the principal investigator on awards from the National Institutes of Health, Centers for Disease Control, John D. and Catherine T. MacArthur Foundation, and Bill & Melinda Gates Foundation. She was granted the prestigious MacArthur award "for genius and creativity" in applying the tools of decision science to public health and in 2009 was elected to the National Academy of Sciences.

Goldie has served on numerous national committees and international advisory boards, including the Board of Global Health at the Institute of Medicine, and as a consultant to the World Health Organization, GAVI and other global alliances, ministries of health, foundations, and industry groups. Her work has influenced clinical guidelines, vaccine policy, and program implementation in low-, middle-, and high-income countries. In 2008, she received the John Eisenberg Award for translation of research to practice. That same year, she was appointed as the Director of the Center for Health Decision Science, a cross-departmental center bridging academia and policy.

In 2010, Goldie was appointed as the founding faculty director of the Harvard Global Health Institute by Harvard President Drew Faust, advancing an ambitious agenda for cross-sectoral collaboration to address global health challenges and playing a key role in initiatives such as the Commission on Global Governance for Health, the Disease Control Priorities Project, and the Commission on Investing in Health. Under her leadership, global perspectives were infused into educational opportunities across the University, with creation of dozens of new courses and learning communities. By the end of her tenure in 2014, more than 5,000 undergraduates had taken courses in global health and the secondary field in global health surpassed economics to become the largest at the college. That year, she was named the Director of the Global Health Education and Learning Incubator at Harvard University, where she continues to promote the integration of global health and global learning within and outside the University, building collaborative cross-disciplinary teaching, creating novel learning spaces, and developing innovative pedagogical tools and approaches.

Goldie is a celebrated educator and teaches core courses in decision science, health policy, and global health at the Harvard Chan School and Harvard College, created the first online course in decision analysis for public health, and co-teaches in a number of interdisciplinary courses across the professional schools. She received the Everett Mendelsohn Excellence in Mentoring Award from Harvard University, and more than a dozen other teaching citations and mentorship awards. Voted a favorite professor by undergraduate students over multiple years, her global health course routinely receives more than 500 applicants. She is a core faculty member in the university-wide PhD Program in Health Policy and serves on the FAS Standing Committee on Health Policy.

Dr. Goldie attended Union College (1984) and Albany Medical College (1988) during which she was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency at Yale University School of Medicine (1988-1991), and an MPH at the Harvard T. H. Chan School of Public Health (1997). She joined the Harvard faculty in 1998, received tenure in 2006, and was named the Roger Irving Lee Professor of Public Health in 2007.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, Bustreo F, Evans D, Feachem RG, Frenk J, Ghosh G, Goldie SJ, Guo Y, Gupta S, Horton R, Kruk ME, Mahmoud A, Mohohlo LK, Ncube M, Pablos-Mendez A, Reddy KS, Saxenian H, Soucat A, Ulltveit-Moe KH, Ulltveit-Moe KH, Yamey G. Global health 2035: a world converging within a generation. Lancet. 2013 Dec 07; 382(9908):1898-955. PMID: 24309475.
    Citations: 316     Fields:    Translation:Humans
  2. Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati M, Stout N, Ward Z, Goldie SJ. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med. 2013; 10(5):e1001451. PMID: 23700390.
    Citations: 13     Fields:    Translation:HumansCells
  3. Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. Vaccine. 2013 Apr 18; 31 Suppl 2:B61-72. PMID: 23598494.
    Citations: 58     Fields:    Translation:HumansPHPublic Health
  4. Goldie SJ, Levin C, Mosqueira-Lovón NR, Ortendahl J, Kim J, O'Shea M, Diaz Sanchez M, Mendoza Araujo MA. Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru. Rev Panam Salud Publica. 2012 Dec; 32(6):426-34. PMID: 23370186.
    Citations: 10     Fields:    Translation:Humans
  5. Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MC. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Eff Resour Alloc. 2012 Sep 19; 10(1):12. PMID: 22992315.
    Citations: 2     
  6. Erim DO, Resch SC, Goldie SJ. Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria. BMC Public Health. 2012 Sep 14; 12:786. PMID: 22978519.
    Citations: 10     Fields:    Translation:Humans
  7. Goldie SJ, O'Shea M, Kim JJ. Finding consensus on cervical cancer prevention. Am J Public Health. 2012 Jun; 102(6):1050-1; author reply 1051. PMID: 22515848; PMCID: PMC3483952.
    Citations:    Fields:    Translation:Humans
  8. Carvalho N, Salehi AS, Goldie SJ. National and sub-national analysis of the health benefits and cost-effectiveness of strategies to reduce maternal mortality in Afghanistan. Health Policy Plan. 2013 Jan; 28(1):62-74. PMID: 22411880.
    Citations: 14     Fields:    Translation:Humans
  9. Goldie SJ, Daniels N. Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparities. J Natl Cancer Inst. 2011 Sep 21; 103(18):1373-86. PMID: 21900120; PMCID: PMC3176779.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  10. Kim SY, Choi Y, Mason PR, Rusakaniko S, Goldie SJ. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience. S Afr Med J. 2011 Sep 05; 101(9):659-64. PMID: 21920160.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  11. Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer. 2012 Jun 01; 130(11):2672-84. PMID: 21717458.
    Citations: 42     Fields:    Translation:HumansCellsPHPublic Health
  12. Kim SY, Sweet S, Chang J, Goldie SJ. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden. BMC Infect Dis. 2011 Jun 16; 11:174. PMID: 21679420.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  13. Price RA, Frank RG, Cleary PD, Goldie SJ. Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests. Med Care. 2011 Feb; 49(2):132-8. PMID: 21150798.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  14. Hsu HE, Rydzak CE, Cotich KL, Wang B, Sax PE, Losina E, Freedberg KA, Goldie SJ, Lu Z, Walensky RP. Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med. 2011 Feb; 12(2):97-108. PMID: 20561082.
    Citations: 8     Fields:    Translation:Humans
  15. Profit J, Lee D, Zupancic JA, Papile L, Gutierrez C, Goldie SJ, Gonzalez-Pier E, Salomon JA. Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med. 2010 Dec 14; 7(12):e1000379. PMID: 21179496.
    Citations: 17     Fields:    Translation:Humans
  16. Rydzak CE, Cotich KL, Sax PE, Hsu HE, Wang B, Losina E, Freedberg KA, Weinstein MC, Goldie SJ. Assessing the performance of a computer-based policy model of HIV and AIDS. PLoS One. 2010 Sep 09; 5(9). PMID: 20844741.
    Citations: 7     Fields:    Translation:HumansCells
  17. Kim SY, Lee G, Goldie SJ. Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infect Dis. 2010 Sep 03; 10:260. PMID: 20815900.
    Citations: 23     Fields:    Translation:HumansPHPublic Health
  18. Levin CE, Sellors J, Shi JF, Ma L, Qiao YL, Ortendahl J, O'Shea MK, Goldie SJ. Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China. Int J Cancer. 2010 Sep 01; 127(6):1404-11. PMID: 20049838.
    Citations: 20     Fields:    Translation:HumansCells
  19. Kim SY, Goldie SJ, Salomon JA. Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam. Med Decis Making. 2010 Sep-Oct; 30(5):E1-E28. PMID: 20729510.
    Citations: 4     Fields:    Translation:HumansCells
  20. Diaz M, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ. Cost-effectiveness of human papillomavirus vaccination and screening in Spain. Eur J Cancer. 2010 Nov; 46(16):2973-85. PMID: 20638840.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  21. Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA. Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):258-68. PMID: 20404739; PMCID: PMC3174771.
    Citations: 33     Fields:    Translation:Humans
  22. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer. 2010 Jun 15; 116(12):2941-53. PMID: 20564399; PMCID: PMC2946062.
    Citations: 30     Fields:    Translation:Humans
  23. Hu D, Grossman D, Levin C, Blanchard K, Adanu R, Goldie SJ. Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana. Afr J Reprod Health. 2010 Jun; 14(2):85-103. PMID: 21243922.
    Citations: 12     Fields:    Translation:Humans
  24. Kim SY, Sweet S, Slichter D, Goldie SJ. Health and economic impact of rotavirus vaccination in GAVI-eligible countries. BMC Public Health. 2010 May 14; 10:253. PMID: 20470426.
    Citations: 29     Fields:    Translation:HumansPHPublic Health
  25. Goldie SJ, Sweet S, Carvalho N, Natchu UC, Hu D. Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysis. PLoS Med. 2010 Apr 20; 7(4):e1000264. PMID: 20421922.
    Citations: 31     Fields:    Translation:Humans
  26. McCabe CJ, Goldie SJ, Fisman DN. The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women. PLoS One. 2010 Apr 13; 5(4):e10154. PMID: 20405011.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  27. Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010 Apr 06; 152(7):409-17, W131-8. PMID: 20368646; PMCID: PMC3086591.
    Citations: 31     Fields:    Translation:Humans
  28. Goldhaber-Fiebert JD, Stout NK, Goldie SJ. Empirically evaluating decision-analytic models. Value Health. 2010 Aug; 13(5):667-74. PMID: 20230547.
    Citations: 12     Fields:    Translation:Humans
  29. Yeh JM, Goldie SJ, Kuntz KM, Ezzati M. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control. 2009 Dec; 20(10):2021-9. PMID: 19642005.
    Citations: 9     Fields:    Translation:HumansCells
  30. Kim JJ, Ortendahl J, Goldie SJ. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med. 2009 Oct 20; 151(8):538-45. PMID: 19841455; PMCID: PMC2779121.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  31. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ. 2009 Oct 08; 339:b3884. PMID: 19815582; PMCID: PMC2759438.
    Citations: 78     Fields:    Translation:HumansPHPublic Health
  32. Goldhaber-Fiebert JD, Denny LA, De Souza M, Kuhn L, Goldie SJ. Program spending to increase adherence: South African cervical cancer screening. PLoS One. 2009 May 28; 4(5):e5691. PMID: 19492097.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  33. Hu D, Grossman D, Levin C, Blanchard K, Goldie SJ. Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City. BJOG. 2009 May; 116(6):768-79. PMID: 19432565.
    Citations: 10     Fields:    Translation:Humans
  34. Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44. PMID: 19367091.
    Citations: 11     Fields:    Translation:Humans
  35. Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health. 2009 Jan 21; 9:29. PMID: 19159483.
    Citations: 28     Fields:    Translation:Humans
  36. Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009 Jan 01; 124(1):157-66. PMID: 18823009; PMCID: PMC2597699.
    Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
  37. Stout NK, Goldie SJ. Keeping the noise down: common random numbers for disease simulation modeling. Health Care Manag Sci. 2008 Dec; 11(4):399-406. PMID: 18998599.
    Citations: 14     Fields:    Translation:Humans
  38. Goldie SJ, O'Shea M, Diaz M, Kim SY. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications. Reprod Health Matters. 2008 Nov; 16(32):86-96. PMID: 19027626.
    Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
  39. Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med. 2008 Sep 22; 168(17):1881-9. PMID: 18809815; PMCID: PMC2746633.
    Citations: 21     Fields:    Translation:Humans
  40. Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis. 2008 Sep; 35(9):775-84. PMID: 18607319.
    Citations: 30     Fields:    Translation:Humans
  41. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008 Aug 21; 359(8):821-32. PMID: 18716299; PMCID: PMC3080183.
    Citations: 108     Fields:    Translation:HumansCells
  42. Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine. 2008 Aug 19; 26 Suppl 12:M89-98. PMID: 18945418.
    Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
  43. Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ. Mathematical models of cervical cancer prevention in the Asia Pacific region. Vaccine. 2008 Aug 19; 26 Suppl 12:M17-29. PMID: 18945411.
    Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
  44. Andrus JK, Lewis MJ, Goldie SJ, García PJ, Winkler JL, Ruiz-Matus C, de Quadros CA. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine. 2008 Aug 19; 26 Suppl 11:L80-7. PMID: 18945405.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  45. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine. 2008 Aug 19; 26 Suppl 10:K76-86. PMID: 18847560.
    Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
  46. Goldie SJ, Diaz M, Constenla D, Alvis N, Andrus JK, Kim SY. Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008 Aug 19; 26 Suppl 11:L59-72. PMID: 18945403.
    Citations: 13     Fields:    Translation:Humans
  47. Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1418-24. PMID: 18848905; PMCID: PMC4340842.
    Citations: 71     Fields:    Translation:Humans
  48. Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008 Aug 19; 26 Suppl 11:L96-L107. PMID: 18945407.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  49. Diaz M, Kim JJ, Albero G, de Sanjosé S, Clifford G, Bosch FX, Goldie SJ. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer. 2008 Jul 22; 99(2):230-8. PMID: 18612311.
    Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
  50. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine. 2008 Jul 29; 26(32):4015-24. PMID: 18602731.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  51. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 2008 Jul 29; 26(32):4080-93. PMID: 18550229.
    Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
  52. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol. 2008 May; 198(5):500.e1-7. PMID: 18455524; PMCID: PMC2441758.
    Citations: 55     Fields:    Translation:HumansCells
  53. Yeh JM, Kuntz KM, Ezzati M, Hur C, Kong CY, Goldie SJ. Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1179-87. PMID: 18483340.
    Citations: 17     Fields:    Translation:HumansCells
  54. Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis. 2008 May 01; 197(9):1324-32. PMID: 18422445; PMCID: PMC2423492.
    Citations: 36     Fields:    Translation:Humans
  55. Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst. 2008 Mar 05; 100(5):308-20. PMID: 18314477.
    Citations: 73     Fields:    Translation:HumansCellsPHPublic Health
  56. Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. Pharmacoeconomics. 2008; 26(3):191-215. PMID: 18282015.
    Citations: 58     Fields:    Translation:HumansPHPublic Health
  57. Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ. 2007 Nov; 85(11):833-42. PMID: 18038073.
    Citations: 20     Fields:    Translation:Humans
  58. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr. 2007 Oct 29; 5:11. PMID: 17967185.
    Citations: 36     Fields:    
  59. Kim JJ, Andres-Beck B, Goldie SJ. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer. 2007 Nov 05; 97(9):1322-8. PMID: 17923869; PMCID: PMC2360471.
    Citations: 42     Fields:    Translation:HumansCellsPHPublic Health
  60. Kwon J, Carey M, Goldie S, Kim J. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol. 2007 Oct; 110(4):933; author reply 933-4. PMID: 17906041.
    Citations:    Fields:    Translation:Humans
  61. Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KA. The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med. 2007 Oct; 8(7):439-50. PMID: 17760736; PMCID: PMC3073616.
    Citations: 9     Fields:    Translation:HumansCells
  62. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007 Sep; 85(9):719-26. PMID: 18026629.
    Citations: 87     Fields:    Translation:Humans
  63. Hu D, Bertozzi SM, Gakidou E, Sweet S, Goldie SJ. The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico. PLoS One. 2007 Aug 15; 2(8):e750. PMID: 17710149.
    Citations: 20     Fields:    Translation:Humans
  64. Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine. 2007 Aug 14; 25(33):6257-70. PMID: 17606315.
    Citations: 49     Fields:    Translation:HumansCellsPHPublic Health
  65. Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol. 2007 Jul 15; 166(2):137-50. PMID: 17526866.
    Citations: 62     Fields:    Translation:HumansCells
  66. Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA. HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS. 2007 May 11; 21(8):973-82. PMID: 17457091; PMCID: PMC2367006.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  67. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries--key challenges and issues. N Engl J Med. 2007 May 10; 356(19):1908-10. PMID: 17494923.
    Citations: 103     Fields:    Translation:HumansCells
  68. Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. Am J Med. 2007 Mar; 120(3):272-9. PMID: 17349451; PMCID: PMC2034752.
    Citations: 5     Fields:    Translation:Humans
  69. Kwon JS, Carey MS, Goldie SJ, Kim JJ. Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer. J Obstet Gynaecol Can. 2007 Feb; 29(2):131-139. PMID: 17346483.
    Citations: 4     Fields:    Translation:Humans
  70. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE, Garcia F. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007 Jan-Feb; 57(1):7-28. PMID: 17237032.
    Citations: 131     Fields:    Translation:Humans
  71. Freedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, Losina E. Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Dec 01; 43 Suppl 1:S113-8. PMID: 17133193.
    Citations: 20     Fields:    Translation:Humans
  72. Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health services when resources are limited: the example of a cervical cancer screening visit. PLoS Med. 2006 Nov; 3(11):e434. PMID: 17105337; PMCID: PMC1635742.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  73. Goldie S. A public health approach to cervical cancer control: considerations of screening and vaccination strategies. Int J Gynaecol Obstet. 2006 Nov; 94 Suppl 1:S95-105. PMID: 17276172.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  74. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med. 2006 Sep 14; 355(11):1141-53. PMID: 16971720.
    Citations: 137     Fields:    Translation:HumansCells
  75. Goldie SJ, Goldhaber-Fiebert JD, Garnett GP. Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/155-63. PMID: 16950003.
    Citations: 28     Fields:    Translation:Humans
  76. Garnett GP, Kim JJ, French K, Goldie SJ. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/178-86. PMID: 16950005.
    Citations: 50     Fields:    Translation:HumansPHPublic Health
  77. Goldhaber-Fiebert JD, Goldie SJ. Estimating the cost of cervical cancer screening in five developing countries. Cost Eff Resour Alloc. 2006 Aug 03; 4:13. PMID: 16887041; PMCID: PMC1570139.
    Citations: 13     
  78. Korves CT, Goldie SJ, Murray MB. Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy. Clin Infect Dis. 2006 Aug 15; 43(4):490-3. PMID: 16838239.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  79. Hu D, Hook EW, Goldie SJ. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis. 2006 Jul; 33(7):428-36. PMID: 16572038.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  80. Kimmel AD, Losina E, Freedberg KA, Goldie SJ. Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. Bull World Health Organ. 2006 Jul; 84(7):581-8. PMID: 16878233; PMCID: PMC2627387.
    Citations: 2     Fields:    Translation:Humans
  81. Goldie SJ, Kim JJ, Myers E. Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/164-70. PMID: 16950004.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  82. Roux L, Kuntz KM, Donaldson C, Goldie SJ. Economic evaluation of weight loss interventions in overweight and obese women. Obesity (Silver Spring). 2006 Jun; 14(6):1093-106. PMID: 16861615.
    Citations: 23     Fields:    Translation:Humans
  83. Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KA. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J. 2006 Jun; 96(6):526-9. PMID: 16841136.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  84. Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ. The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health. 2006 Apr; 16(2):185-92. PMID: 16469759.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  85. Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States. PLoS Med. 2006 Feb; 3(2):e21. PMID: 16381598; PMCID: PMC1324950.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  86. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006 Jan 18; 98(2):92-100. PMID: 16418511.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  87. O'Mara JE, Fisher JD, Goldie SJ, Kim SG, Ferrick KJ, Gross JN, Palma EC. Effects of cardioactive medications on retrograde conduction: continuing relevance for current devices. J Interv Card Electrophysiol. 2006 Jan; 15(1):49-55. PMID: 16680550.
    Citations:    Fields:    Translation:Humans
  88. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, Wright TC. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005 Nov 17; 353(20):2158-68. PMID: 16291985.
    Citations: 189     Fields:    Translation:HumansCellsPHPublic Health
  89. Goldhaber-Fiebert JD, Denny LE, De Souza M, Wright TC, Kuhn L, Goldie SJ. The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc. 2005 Nov 15; 3:11. PMID: 16288646; PMCID: PMC1308836.
    Citations: 20     
  90. Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005 Nov 01; 41(9):1316-23. PMID: 16206108.
    Citations: 52     Fields:    Translation:HumansCells
  91. Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS. 2005 Aug 12; 19(12):1299-308. PMID: 16052085.
    Citations: 43     Fields:    Translation:Humans
  92. Aledort JE, Hook EW, Weinstein MC, Goldie SJ. The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis. 2005 Jul; 32(7):425-36. PMID: 15976600.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  93. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst. 2005 Jun 15; 97(12):888-95. PMID: 15956650.
    Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
  94. Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. J Acquir Immune Defic Syndr. 2005 May 01; 39(1):69-77. PMID: 15851916.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  95. Smith Fawzi MC, Lambert W, Singler JM, Tanagho Y, Léandre F, Nevil P, Bertrand D, Claude MS, Bertrand J, Louissaint M, Jeannis L, Mukherjee JS, Goldie S, Salazar JJ, Farmer PE. Factors associated with forced sex among women accessing health services in rural Haiti: implications for the prevention of HIV infection and other sexually transmitted diseases. Soc Sci Med. 2005 Feb; 60(4):679-89. PMID: 15571887.
    Citations: 18     Fields:    Translation:Humans
  96. Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antivir Ther. 2005; 10(1):41-52. PMID: 15751762.
    Citations: 7     Fields:    Translation:Humans
  97. Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz K. Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment. Health Care Financ Rev. 2005; 26(4):67-80. PMID: 17288069; PMCID: PMC4194909.
    Citations: 2     Fields:    Translation:Humans
  98. Hu D, Hook EW, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med. 2004 Oct 05; 141(7):501-13. PMID: 15466767.
    Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
  99. Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KA. A therapeutic HIV vaccine: how good is good enough? Vaccine. 2004 Sep 28; 22(29-30):4044-53. PMID: 15364455.
    Citations: 7     Fields:    Translation:Humans
  100. Salomon JA, Weinstein MC, Goldie SJ. Taking account of future technology in cost effectiveness analysis. BMJ. 2004 Sep 25; 329(7468):733-6. PMID: 15388618; PMCID: PMC518904.
    Citations: 9     Fields:    Translation:Humans
  101. Schackman BR, Oneda K, Goldie SJ. The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS. 2004 Sep 03; 18(13):1827-34. PMID: 15316344.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  102. Anhang R, Goodman A, Goldie SJ. HPV communication: review of existing research and recommendations for patient education. CA Cancer J Clin. 2004 Sep-Oct; 54(5):248-59. PMID: 15371283.
    Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
  103. Goldie S, Palefsky JM, Workowsi K. Anal cancer in HIV infection: to screen or not to screen? AIDS Clin Care. 2004 Jul; 16(7):53-5, 57. PMID: 15300925.
    Citations: 1     Fields:    Translation:Humans
  104. Kim JJ, Leung GM, Woo PP, Goldie SJ. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health (Oxf). 2004 Jun; 26(2):130-7. PMID: 15284314.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  105. Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ. When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004 May; 13(5):429-36. PMID: 15127423.
    Citations: 30     Fields:    Translation:Humans
  106. Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004 Apr 21; 96(8):604-15. PMID: 15100338.
    Citations: 123     Fields:    Translation:HumansCellsPHPublic Health
  107. Goldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004 Apr; 103(4):619-31. PMID: 15051550.
    Citations: 47     Fields:    Translation:HumansCells
  108. Wright TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004 Feb; 103(2):304-9. PMID: 14754700.
    Citations: 100     Fields:    Translation:HumansCellsPHPublic Health
  109. Anhang R, Wright TC, Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer. 2004 Jan 15; 100(2):315-20. PMID: 14716766.
    Citations: 24     Fields:    Translation:HumansCells
  110. Anhang R, Stryker JE, Wright TC, Goldie SJ. News media coverage of human papillomavirus. Cancer. 2004 Jan 15; 100(2):308-14. PMID: 14716765.
    Citations: 14     Fields:    Translation:HumansCells
  111. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003 Dec 01; 115(8):632-41. PMID: 14656616.
    Citations: 40     Fields:    Translation:Humans
  112. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003 Oct 10; 106(6):896-904. PMID: 12918067.
    Citations: 44     Fields:    Translation:HumansCells
  113. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA. 2003 Jul 09; 290(2):228-37. PMID: 12851278.
    Citations: 73     Fields:    Translation:Humans
  114. Wittenberg E, Goldie SJ, Fischhoff B, Graham JD. Rationing decisions and individual responsibility for illness: are all lives equal? Med Decis Making. 2003 May-Jun; 23(3):194-211. PMID: 12809318.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  115. Yeh JM, Hook EW, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003 May; 30(5):369-78. PMID: 12916126.
    Citations: 19     Fields:    Translation:Humans
  116. Goldie SJ, Kuntz KM. A potential error in evaluating cancer screening: a comparison of 2 approaches for modeling underlying disease progression. Med Decis Making. 2003 May-Jun; 23(3):232-41. PMID: 12809321.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  117. Fisman DN, Hook EW, Goldie SJ. Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex Transm Infect. 2003 Feb; 79(1):45-52. PMID: 12576614.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  118. Goldie SJ. Chapter 15: Public health policy and cost-effectiveness analysis. J Natl Cancer Inst Monogr. 2003; (31):102-10. PMID: 12807953.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  119. Yazdanpanah Y, Goldie SJ, Paltiel AD, Losina E, Coudeville L, Weinstein MC, Gerard Y, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis. 2003 Jan 01; 36(1):86-96. PMID: 12491207.
    Citations: 11     Fields:    Translation:Humans
  120. Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Antivir Ther. 2002 Dec; 7(4):257-66. PMID: 12553480.
    Citations: 13     Fields:    Translation:Humans
  121. Kuehne FC, Bethe U, Freedberg K, Goldie SJ. Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness. Arch Intern Med. 2002 Dec 9-23; 162(22):2545-56. PMID: 12456226.
    Citations: 4     Fields:    Translation:Humans
  122. Wright TC, Denny L, Kuhn L, Goldie S. Use of visual screening methods for cervical cancer screening. Obstet Gynecol Clin North Am. 2002 Dec; 29(4):701-34. PMID: 12509093.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  123. Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med. 2002 Nov 25; 162(21):2478-86. PMID: 12437408.
    Citations: 20     Fields:    Translation:HumansCells
  124. Goldie SJ. Health economics and cervical cancer prevention: a global perspective. Virus Res. 2002 Nov; 89(2):301-9. PMID: 12445670.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  125. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol. 2002 Oct 15; 156(8):761-73. PMID: 12370165.
    Citations: 40     Fields:    Translation:HumansPHPublic Health
  126. Fisman DN, Lipsitch M, Hook EW, Goldie SJ. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis. 2002 Oct; 29(10):608-22. PMID: 12370529.
    Citations: 22     Fields:    Translation:HumansCells
  127. Corso PS, Hammitt JK, Graham JD, Dicker RC, Goldie SJ. Assessing preferences for prevention versus treatment using willingness to pay. Med Decis Making. 2002 Sep-Oct; 22(5 Suppl):S92-101. PMID: 12369235.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  128. Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31(1):27-37. PMID: 12352147.
    Citations: 9     Fields:    Translation:Humans
  129. Seage GR, Losina E, Goldie SJ, Paltiel AD, Kimmel AD, Freedberg KA. The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality. J Acquir Immune Defic Syndr. 2002 Aug 01; 30(4):421-8. PMID: 12138349.
    Citations: 9     Fields:    Translation:HumansCells
  130. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002 May 08; 287(18):2382-90. PMID: 11988059.
    Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
  131. Kuntz KM, Goldie SJ. Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity bias. Med Decis Making. 2002 May-Jun; 22(3):218-27. PMID: 12058779.
    Citations: 12     Fields:    Translation:Humans
  132. Johri M, David Paltiel A, Goldie SJ, Freedberg KA. State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards. Med Care. 2002 May; 40(5):429-41. PMID: 11961477.
    Citations: 10     Fields:    Translation:Humans
  133. Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. Arch Intern Med. 2002 Apr 22; 162(8):921-8. PMID: 11966344.
    Citations: 13     Fields:    Translation:Humans
  134. Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MC. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making. 2002 Jan-Feb; 22(1):27-38. PMID: 11833663.
    Citations: 47     Fields:    Translation:Humans
  135. Goldie SJ, Levin AR. msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis. JAMA. 2001 Oct 03; 286(13):1637-8. PMID: 11585493.
    Citations: 2     Fields:    Translation:Humans
  136. Zanetti G, Goldie SJ, Platt R. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis. 2001 Sep-Oct; 7(5):820-7. PMID: 11747694; PMCID: PMC2631870.
    Citations: 6     Fields:    Translation:HumansCells
  137. Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA. Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health. 2001 Sep; 91(9):1456-63. PMID: 11527782; PMCID: PMC1446805.
    Citations: 14     Fields:    Translation:Humans
  138. Wittenberg E, Goldie SJ, Graham JD. Predictors of hazardous child seating behavior in fatal motor vehicle crashes: 1990 to 1998. Pediatrics. 2001 Aug; 108(2):438-42. PMID: 11483812.
    Citations: 2     Fields:    Translation:Humans
  139. Yazdanpanah Y, Chêne G, Losina E, Goldie SJ, Merchadou LD, Alfandari S, Seage GR, Sullivan L, Marimoutou C, Paltiel AD, Salamon R, Mouton Y, Freedberg KA. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol. 2001 Aug; 30(4):864-71. PMID: 11511618.
    Citations: 19     Fields:    Translation:Humans
  140. Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KM. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med. 2001 Aug; 111(2):140-9. PMID: 11498068.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  141. Hagen MD, Garber AM, Goldie SJ, Lafata JE, Mandelblatt J, Meltzer D, Neumann P, Siegel JE, Sox HC, Tsevat J. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium. Med Decis Making. 2001 Jul-Aug; 21(4):307-23. PMID: 11475387.
    Citations: 2     Fields:    Translation:Humans
  142. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA. 2001 Jun 27; 285(24):3107-15. PMID: 11427139.
    Citations: 77     Fields:    Translation:HumansCellsPHPublic Health
  143. Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KA. Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med. 2001 Mar 20; 134(6):440-50. PMID: 11255519.
    Citations: 54     Fields:    Translation:HumansCells
  144. Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001 Mar 15; 344(11):824-31. PMID: 11248160.
    Citations: 155     Fields:    Translation:Humans
  145. Paltiel AD, Goldie SJ, Losina E, Weinstein MC, Seage GR, Kimmel AD, Zhang H, Freedberg KA. Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus. Clin Infect Dis. 2001 Mar 01; 32(5):783-93. PMID: 11229847.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  146. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis. 2001 Feb 01; 32(3):419-30. PMID: 11170950.
    Citations: 40     Fields:    Translation:Humans
  147. Shireman TI, Tsevat J, Goldie SJ. Time costs associated with cervical cancer screening. Int J Technol Assess Health Care. 2001; 17(1):146-52. PMID: 11329841.
    Citations: 17     Fields:    Translation:Humans
  148. Wright TC, Goldie SJ, Cain JM, Howett MK. Screening for cervical cancer. Science. 2000 Dec 01; 290(5497):1651. PMID: 11186376.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  149. Mrus JM, Goldie SJ, Weinstein MC, Tsevat J. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS. 2000 Nov 10; 14(16):2543-52. PMID: 11101066.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  150. Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ. Cost-utility analyses of clinical preventive services: published ratios, 1976-1997. Am J Prev Med. 2000 Jul; 19(1):15-23. PMID: 10865159.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  151. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000 Jun 01; 108(8):634-41. PMID: 10856411.
    Citations: 53     Fields:    Translation:HumansPHPublic Health
  152. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000; 21:587-611. PMID: 10884966.
    Citations: 110     Fields:    Translation:HumansPHPublic Health
  153. Yazdanpanah Y, Goldie SJ, Salamon R, Mouton Y, Freedberg KA. Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1? Lancet. 1999 Oct 09; 354(9186):1305-6. PMID: 10520668.
    Citations:    Fields:    Translation:HumansCells
  154. Macones GA, Goldie SJ, Peipert JF. Cost-effectiveness analysis: an introductory guide for clinicians. Obstet Gynecol Surv. 1999 Oct; 54(10):663-72. PMID: 10511966.
    Citations: 2     Fields:    Translation:Humans
  155. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999 May 19; 281(19):1822-9. PMID: 10340370.
    Citations: 101     Fields:    Translation:HumansPHPublic Health
  156. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med. 1999 Jan 19; 130(2):97-107. PMID: 10068381.
    Citations: 21     Fields:    Translation:Humans
  157. Graham JD, Goldie SJ, Segui-Gomez M, Thompson KM, Nelson T, Glass R, Simpson A, Woerner LG. Reducing risks to children in vehicles with passenger airbags. Pediatrics. 1998 Jul; 102(1):e3. PMID: 9651455.
    Citations: 2     Fields:    Translation:Humans
  158. Paltiel AD, Scharfstein JA, Seage GR, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making. 1998 Apr-Jun; 18(2 Suppl):S93-105. PMID: 9566470.
    Citations: 24     Fields:    Translation:Humans
  159. Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. The cost-effectiveness of air bags by seating position. JAMA. 1997 Nov 05; 278(17):1418-25. PMID: 9356000.
    Citations: 16     Fields:    Translation:Humans
  160. Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Cytomegalovirus as a primary pulmonary pathogen in AIDS. Chest. 1997 Jan; 111(1):128-34. PMID: 8996006.
    Citations: 8     Fields:    Translation:HumansCells
  161. Troidle L, Kliger AS, Goldie SJ, Gorban-Brennan N, Brown E, Fikrig M, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Perit Dial Int. 1996 Sep-Oct; 16(5):505-10. PMID: 8914180.
    Citations: 3     Fields:    Translation:HumansCells
  162. D'Arcy C, Ham MV, Goldie S. The development of a comprehensive psychiatric service utilization research data file. Can J Public Health. 1976 May-Jun; 67(3):237-48. PMID: 1277088.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. FAS faculty should contact the Office for Scholarly Communication (oschulmail.harvard.edu) for general questions about Profiles. For data questions, please contact Raelyn Lincoln (raelyn_lincolnharvard.edu) from the FAS Division of Science; Jennifer Shephard (jmshephfas.harvard.edu) from the FAS Division of Social Science; or Alexander Parker (afparkerfas.harvard.edu) from the FAS Division of Arts and Humanities.
Goldie's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (515)
Co-Authors (37)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.